Original Research
Published on 16 Dec 2020
Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy
in Pediatric Oncology

- 4,385 views
- 8 citations
Original Research
Published on 16 Dec 2020
in Pediatric Oncology
Review
Published on 12 Nov 2020
in Pediatric Oncology
Original Research
Published on 30 Oct 2020
in Pediatric Oncology
Systematic Review
Published on 27 Oct 2020
in Pediatric Oncology
Review
Published on 23 Oct 2020
in Pediatric Oncology
Review
Published on 22 Oct 2020
in Pediatric Oncology
Original Research
Published on 20 Aug 2020
in Pediatric Oncology
Original Research
Published on 12 Aug 2020
in Pediatric Oncology
Original Research
Published on 11 Aug 2020
in Pediatric Oncology
Original Research
Published on 16 Jul 2020
in Pediatric Oncology
Clinical Trial
Published on 05 Jun 2020
in Pediatric Oncology
Original Research
Published on 09 Apr 2020
in Pediatric Oncology
Original Research
Published on 27 Mar 2020
in Pediatric Oncology
Editorial
Published on 10 Mar 2020
in Pediatric Oncology
Original Research
Published on 19 Jun 2019
in Pediatric Oncology
Mini Review
Published on 14 Mar 2019
in Pediatric Oncology